Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-005571 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
13,469
Total Value
$346,454.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reporting Person's Title: Executive Vice President and Chief Medical Officer | Common Stock | โ | Feb 2, 2026 | Sale | 3,675 | $25.50 | $93,706.62 | 90,445 | Direct | โ | View Details | |
Reporting Person's Title: Executive Vice President and Chief Medical Officer | Common Stock | โ | Feb 4, 2026 | Sale | 9,794 | $25.81 | $252,747.88 | 80,651 | Direct | โ | View Details |